Education
About Us
Working with TipRanks
Follow Us
Kevin Rod Insider Profile
4 Followers
Kevin Rod, Ten Percent Owner at Optima Medical Innovations, holds 26.92M shares in Optima Medical Innovations (Ticker: TOKIF). Most recently, Kevin Rod ― shares of Optima Medical Innovations on ― for an estimated value of ―.
Kevin Rod Optima Medical Innovations (TOKIF)Ten Percent Owner
Optima Medical Innovations (TOKIF)
Ten Percent Owner
Not Ranked
Kevin Rod has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Kevin Rod does not currently own shares as a corporate insider.
A breakdown of Kevin Rod's holdings
Insider Roles
Kevin Rod does not currently hold a role as a corporate insider.
Roles that Kevin Rod holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Rod
Kevin Rod's Trading History
List of latest transactions for each holding click on a transaction to see Kevin Rod's performance on stock
You May Also Like
Kevin Rod insider profile FAQ
What is the percentage of profitable transactions made by Kevin Rod?
The percentage of profitable transactions made by Kevin Rod is ―.
What is the average return per transaction made by Kevin Rod?
The average return per transaction made by Kevin Rod is ―.
What stocks does Kevin Rod hold?
Kevin Rod holds: TOKIF stocks.
What was Kevin Rod’s latest transaction?
Kevin Rod latest transaction was an Uninformative Buy of ―.
What was Kevin Rod's most profitable transaction?
Kevin Rod’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Rod's role in Optima Medical Innovations?
Kevin Rod's role in Optima Medical Innovations is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.